BioSpace News Archive

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., is collaborating with Indiana University of Pennsylvania (IUP), and Indiana Regional Medical Center (IRMC) to enable better and faster COVID-19 testing for rural communities in the United States and around the world.

CE marked assay based on well-established ELISA technology expands EUROIMMUN’s offerings for labs that seek to understand immune response to COVID-19

Kadmon Holdings, Inc. announced that the first patient has been dosed in an open-label Phase 2 clinical trial of belumosudil, the Company’s ROCK2 inhibitor, in patients with diffuse cutaneous systemic sclerosis, a chronic immune disorder characterized by fibrosis of the skin and internal organs.

Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced that a poster highlighting the Company’s ongoing Phase I/II OVATION 2 Study with GEN-1 in advanced ovarian cancer was presented last week at the Virtual Annual Meeting on Women’s Cancer, sponsored by the Society of Gynecologic Oncology.

Korro Bio, Inc. , an RNA editing company focused on the discovery and development of novel genetic medicines, today announced the appointment of Howard Stern, M.D., Ph.D. as Chief Scientific Officer. Dr. Stern is a seasoned biotechnology executive with extensive experience in drug discovery and development,

Generated dramatic growth in total and pro forma revenue Released positive clinical data on its patented drug delivery technology and received new certifications at its research facility Acquired and expanded consumer wellness subsidiary The Sera Labs, Inc.

The American Urological Association and Urology Care Foundation announced the launch of a program aimed at fostering diversity and inclusion in urology research, supported by a generous $2 million donation from Urovant Sciences.

Life Sciences organizations can now turn to MedPro Systems for comprehensive compliance guidance and solutions from an in-house team of pharmaceutical and medical device experts

Women, the Black community and Gen Z are the three groups most likely to resist receiving the COVID-19 vaccine, according to a recent study conducted by LevLane Inc. and MarketVision Research, Inc.

Providing answers, education and support during Sarcoidosis Awareness Month is more important than ever during COVID-19 pandemic